Learn more about NYSCF’s latest announcements, statements and research breakthroughs.
Uniting cutting-edge genomics, stem cell science, and AI-enabled data science to accelerate the discovery of life-changing therapies (Maine and New York — July 9, 2025) —...
Partnership Will Harness NYSCF’s Automated Cell Culture Systems and Artificial Intelligence Capabilities to Study Disease at an Unprecedented Cellular Level NEW YORK, NY (January 10, 2025)...
Partnership combines advanced cellular tagging with ethnically diverse stem cell lines, addressing critical gaps in biomedical research Seattle, WA and New York, NY – September 4,...
Largest collection of patient stem cell models of multiple sclerosis to date uncovers novel disease insights and opens the door for new treatments NEW YORK, NY...
Former Hunter College President Takes Helm of Globally Respected Institute Seeking Cures for Major Diseases Through Stem Cell Science
The New York Stem Cell Foundation (NYSCF) today announced the 2023 class of NYSCF – Robertson Investigators, welcoming three outstanding stem cell researchers into the NYSCF...
The New York Stem Cell Foundation (NYSCF) announced Dr. Derrick Rossi, a member of the NYSCF Board of Directors and co-founder of Moderna, as Interim CEO...
First induced pluripotent stem cell model of PTSD offers insights into underlying genetics and opportunities for new therapies (Sign up for our upcoming webinar on November...
The New York Stem Cell Foundation (NYSCF) today announced the 2022 class of NYSCF – Robertson Investigators, welcoming six outstanding stem cell researchers and neuroscientists into...
NEW YORK, NY (September 9, 2022) – The New York Stem Cell Foundation (NYSCF) today announced the death of its Chief Executive Officer and Co-Founder, Susan...
New York Stem Cell Foundation (NYSCF) Research Institute collaborates with Google Research to identify new cellular characteristics of disease in skin cells from Parkinson’s patients NEW...
New York, NY (October 19, 2021) – The New York Stem Cell Foundation (NYSCF) today announced the 2021 class of NYSCF – Robertson Investigators, welcoming six...
The New York Stem Cell Foundation (NYSCF) today announced that they are developing a stem cell therapy to treat patients suffering from age-related macular degeneration (AMD)....
Top row: Drs. Raffaella Di Micco, Samantha Morris, José Ordovás-Montañés. Bottom row: Drs. Jiami Guo, David Schneider, John Tuthill New York, NY (October 20, 2020) – The...
Human stem-cell-derived astrocytes can be triggered to become toxic to neurons, opening the door for new understanding and treatment of neurodegenerative diseases. Featured image credit: Christina...
Research teams will use stem cell and gene editing technologies to advance NK cell-based therapies for cancer New York, New York (January 9, 2020) – The...
First patient-derived, induced pluripotent stem cell disease-specific organoid models in microgravity to advance understanding of neurodegenerative disease LOUISVILLE, KY — (BUSINESS WIRE) — The National Stem...
New York, NY (October 22, 2019) – The New York Stem Cell Foundation (NYSCF) today announced the 2019 class of NYSCF – Robertson Investigators, welcoming six...
Four-year Study of over 500 Research Institutions Identifies Widespread Gender Imbalance New York, NY (September 5, 2019) – Teams from the New York Stem Cell Foundation...
Research teams will use stem cell and gene editing technologies to advance cell-based therapies for devastating diseases New York, New York (January 9, 2019) – The...
NEW YORK, NY (October 23, 2018) – The New York Stem Cell Foundation (NYSCF) announced the 2018 class of NYSCF – Robertson Investigators, welcoming six of...
New collaboration aims to develop better therapies New York, NY (August 1, 2018) – The New York Stem Cell Foundation (NYSCF) Research Institute today announced a...
Protocol adds a new cell type enabling myelination in human ‘mini-brains’ for laboratory research New York, NY (July 25, 2018) – In a collaborative study between...
Scientists from the New York Stem Cell Foundation (NYSCF) Research Institute have developed a new bone engineering technique called Segmental Additive Tissue Engineering (SATE). The technique,...
NYSCF welcomed six of the most talented stem cell researchers and neuroscientists from around the world into the NYSCF Investigator Program and the NYSCF Innovator Community....
